To Reduce Prescription Prices, Hold Middlemen Accountable

Law360 (June 23, 2021, 3:02 PM EDT) -- President Joe Biden froze all the rules and regulations issued in the Trump administration's final days. Such pauses are fairly common; new presidents typically want to review, and sometimes shelve, their predecessors' last-minute gambits.

But unfortunately, Biden's freeze has delayed a prescription drug reform that could save Medicare beneficiaries billions at the pharmacy counter.[1] Quickly implementing that rule — which targets middlemen in the drug supply chain — would help safeguard seniors' health.

Tens of millions of Americans struggle at the pharmacy. The Kaiser Family Foundation found that 30% of patients don't take their prescriptions as prescribed due to cost —...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!